Please login to the form below

Not currently logged in
Email:
Password:

Professor Carole Longson moves from NICE to the ABPI

She joins the UK pharma body as its chief scientific officer

The Association of the British Pharmaceutical Industry (ABPI) has attracted Professor Carole Longson away from the National Institute for Health and Care Excellence (NICE) to be its new chief scientific officer, handing her responsibility for leading the UK trade body's research, medical and innovation functions.

She will also shape and develop UK pharmaceutical science policy and will ensure that the UK “remains at the forefront of innovation in medicines research, development and manufacturing”.

Mike Thompson, chief executive of the ABPI, said: “The appointment of Carole to this new post signals our commitment to strengthening our focus on science, research and discovery in the UK and the role our members play in developing new innovative medicines and vaccines.

“Her scientific research and academic experience, along with her integrity, perspective and vision can really help us continue to transform the pharmaceutical industry in the UK.”

Longson brings research, academic and pharmaceutical industry experience to the ABPI, including seven years as a research lead at GlaxoSmithKline.

She most recently spent the 18 years at the National Institute for Health and Care Excellence (NICE), where she has led the HTA organisation’s technology appraisal programme.

Neil Weir, chair of the ABPI innovation board, said: “I am delighted by the appointment of Carole to the role of chief scientific officer at the ABPI and her significant scientific experience, expertise and network in both industry and academia will enable the ABPI to work with our partners to further these objectives.”

30th January 2018

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics